Leggett Thomas
SEC insider (Form 3/4/5 filer). CIK 0001774690. Chief Financial Officer at Stoke Therapeutics, Inc. (STOK). 10 reported Form 4/5 transactions since Sep 2024; latest on Mar 18, 2026. Located in BEDFORD, MA.
Companies Leggett Thomas has filed insider reports for
- Stoke Therapeutics, Inc. (STOK): Officer, Chief Financial Officer
Leggett Thomas
CIK: 0001774690
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Stoke Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect37 shares at avg. $32.85$1K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect2.2K shares at avg. $31.28$68K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect172 shares at avg. $31.79$5K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect1.3K shares at avg. $32.74$42K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect922 shares at avg. $33.38$31K - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
ExerciseDirect14.8K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
60K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AwardDirectRestricted Stock Units
40K shares- - Mar 20, 2025STOK
Stoke Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
89K shares- - Mar 20, 2025STOK
Stoke Therapeutics, Inc.
AwardDirectRestricted Stock Units
59K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 37 | $32.85 | $1,215 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 2,173 | $31.28 | $67,980 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 172 | $31.79 | $5,468 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 1,274 | $32.74 | $41,710 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 922 | $33.38 | $30,772 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise | 14,750 | - | $0 | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 60,000 | - | - | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award Restricted Stock Units | 40,000 | - | - | Direct |
| Mar 20, 2025 | STOK Stoke Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 89,000 | - | - | Direct |
| Mar 20, 2025 | STOK Stoke Therapeutics, Inc. | Award Restricted Stock Units | 59,000 | - | - | Direct |
1-10 of 10 transactions